OnKure Therapeutics (OKUR) News Today $5.46 0.00 (0.00%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$5.44 -0.01 (-0.27%) As of 02/21/2025 04:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Deep Track Capital, LP Acquires Shares in OnKure Therapeutics IncFebruary 14, 2025 | gurufocus.comHighbridge Capital Management LLC Acquires Significant Stake in OnKure Therapeutics IncFebruary 7, 2025 | gurufocus.comJonesTrading Reaffirms Their Buy Rating on OnKure Therapeutics (OKUR)February 6, 2025 | markets.businessinsider.comVanguard Group Inc's Strategic Acquisition of OnKure Therapeutics SharesJanuary 31, 2025 | gurufocus.comJones Trading Initiates Coverage of OnKure Therapeutics (OKUR) with Buy RecommendationJanuary 30, 2025 | msn.comOnKure Therapeutics initiated with a Buy at JonesResearchJanuary 29, 2025 | markets.businessinsider.comJones Trading sets OnKure stock Buy rating, $32 targetJanuary 29, 2025 | msn.comOnKure Therapeutics, Inc. (OKUR)January 7, 2025 | finance.yahoo.comOnKure Therapeutics Inc Class A Shares OKURDecember 22, 2024 | morningstar.comOppenheimer Remains a Buy on OnKure Therapeutics (OKUR)December 12, 2024 | markets.businessinsider.comOnKure Therapeutics announces safety, pharmacokinetic data on OKI-219December 11, 2024 | markets.businessinsider.comOnKure Therapeutics Reports Positive Preliminary Data From First-in-human Study Of OKI-219December 10, 2024 | markets.businessinsider.comOnKure Therapeutics Advances Cancer Drug TrialsDecember 10, 2024 | tipranks.comOnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219December 10, 2024 | globenewswire.comLeerink Partners Initiates Coverage of OnKure Therapeutics (OKUR) with Outperform RecommendationDecember 5, 2024 | msn.comOnKure Therapeutics Inc Class A SharesDecember 5, 2024 | morningstar.comOnKure Therapeutics Reports Strategic Merger and Financial UpdatesNovember 26, 2024 | markets.businessinsider.comOnKure Announces New Date for Upcoming Investor CallNovember 25, 2024 | globenewswire.comOnKure Therapeutics Faces Post-Merger Hurdles: Integration Challenges and Talent Competition Threaten GrowthNovember 9, 2024 | tipranks.comOnKure Therapeutics' (OKUR) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $40.00 price target on shares of OnKure Therapeutics in a report on Friday.November 8, 2024 | marketbeat.comOnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer SymposiumNovember 1, 2024 | globenewswire.comQ3 Earnings Forecast for OKUR Issued By HC WainwrightOnKure Therapeutics (NASDAQ:OKUR - Free Report) - Analysts at HC Wainwright issued their Q3 2024 earnings estimates for OnKure Therapeutics in a report released on Thursday, October 17th. HC Wainwright analyst R. Burns anticipates that the company will earn ($1.03) per share for the quarter. HC WOctober 21, 2024 | marketbeat.comWhat is HC Wainwright's Estimate for OKUR Q1 Earnings?OnKure Therapeutics (NASDAQ:OKUR - Free Report) - Equities researchers at HC Wainwright issued their Q1 2025 earnings per share estimates for OnKure Therapeutics in a research report issued on Thursday, October 17th. HC Wainwright analyst R. Burns anticipates that the company will post earnings oOctober 18, 2024 | marketbeat.comOnKure Therapeutics (NASDAQ:OKUR) Earns Buy Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $40.00 price objective on shares of OnKure Therapeutics in a research report on Thursday.October 17, 2024 | marketbeat.com Get OnKure Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OKUR and its competitors with MarketBeat's FREE daily newsletter. Email Address OKUR Media Mentions By Week OKUR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OKUR News Sentiment▼0.000.60▲Average Medical News Sentiment OKUR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OKUR Articles This Week▼01▲OKUR Articles Average Week Get OnKure Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OKUR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Forte Biosciences News Avalo Therapeutics News Applied Therapeutics News InterCure News Mural Oncology News Gain Therapeutics News PMV Pharmaceuticals News Ikena Oncology News Mersana Therapeutics News Aerovate Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OKUR) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OnKure Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share OnKure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OKUR Stock Alerts